ProCE Banner Activity

Clinical Role of PARP1, BRCA, and Other DNA Damage Repair Genes and Genetic Testing in Prostate Cancer

Slideset Download
Get up to date on how PARP inhibitors target tumor cells with DNA repair deficiencies as well as germline and somatic testing in patients with prostate cancer.

Released: July 09, 2020

Expiration: July 08, 2021

Share

Faculty

Celestia S. Higano

Celestia S. Higano, MD, FACP

Professor
University of Washington
Departments of Urology and Medicine
Member
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Celestia S. Higano, MD, FACP

Professor
University of Washington
Departments of Urology and Medicine
Member
Fred Hutchinson Cancer Research Center
Seattle, Washington